OCGN Q3 2018 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$710M

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$7M

Net Income

$11M

EPS (Diluted)

$-14.40

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$6M

Stock-Based Comp.

$439,000

Balance Sheet

Total Assets

$11M

Total Liabilities

$21M

Stockholders' Equity

-$10M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$7M	-$6M	-22.3%
Net Income	$11M	-$6M	+277.6%